Results
|
|
1.
|
Optical coherence tomography assessment of acute thrombogenicity at bifurcation sites using different stenting techniques: A porcine arteriovenous shunt study. MedStar authors:
- Bhogal, Sukhdeep
- Dan, Kazuhiro
- Devineni, Aditya
- Garcia-Garcia, Hector M
- Hellinga, David
- Kuku, Kayode O
- Melaku, Gebremedhin
- Waksman, Ron
Year: 2022
Citation: - Catheterization & Cardiovascular Interventions. 99(7):1998-2005, 2022 Jun.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Advanced Cardiac Catheterization Research Fellowship
Medline publication type:
All authors: - Bhogal S, Dan K, Devineni A, Garcia-Garcia HM, Hellinga D, Kuku KO, Melaku GD, Waksman R
|
|
|
2.
|
|
|
|
3.
|
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials. [Review] MedStar authors:
Year: 2021
Citation: - American Heart Journal. 235:140-148, 2021 05.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Asami M, Iglesias JF, Kandzari DE, Koolen J, Lefevre T, Muller O, Piccolo R, Pilgrim T, Rothenbuhler M, Saito S, Siontis GC, Slagboom T, Waksman R, Windecker S
|
|
|
4.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
|
|
5.
|
|
|
|
6.
|
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
|
7.
|
In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries. MedStar authors:
- Baffour, Richard
- Chan, Rosanna
- Hellinga, David
- Pakala, Rajbabu
- Seabron, Rufus
- Waksman, Ron
Year: 2012
Citation: - Catheterization & Cardiovascular Interventions. 80(3):429-36, 2012 Sep 1.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
All authors: - Baffour R, Chan R, Hellinga D, Kolodgie F, Pakala R, Seabron R, Su SH, Virmani R, Waksman R
|
|
|
8.
|
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial. MedStar authors:
Year: 2015
Citation: - Circulation: Cardiovascular Interventions. 8(2):e001441, 2015 Feb.
Institution: - MedStar Heart & Vascular Institute
All authors: - Barragan P, Bilger J, Cook S, Erne P, Goicolea J, Haude M, Juni P, Lefevre T, Merkely B, Neumann FJ, Piot C, Richardt G, Sabate M, Schneider H, Slagboom T, Stangl K, Waksman R, Windecker S, Witzenbichler B, Zaugg S
|
|
|
9.
|
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
|
|
|
10.
|
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. MedStar authors:
Year: 2013
Citation: - Eurointervention. 9(3):308-15, 2013 Jul.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Allocco DJ, Banning A, Barragan P, Dawkins KD, Kelbaek H, Kubica J, Masotti M, Meredith IT, Scott D, Sjogren I, Stables RH, Thuesen L, Valdes Chavarri M, Verheye S, Walters DL, Weissman NJ, West NE, Whitbourn R
|
